ET
JANX icon

Entropy Technologies’s Janux Therapeutics JANX Stock Holding History

Entropy Technologies’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Buy
26,795
+16,094
+150% +$233K 0.02% 712
2026
Q1 		$149K Sell
10,701
-5,407
-34% -$74.1K 0.01% 831
2025
Q4 		$222K Buy
+16,108
New +$379K 0.01% 781

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Entropy Technologies's JANX Position: Q2 2026 in Review

Entropy Technologies increased its Janux Therapeutics (JANX) stake by 150% in Q2 2026, buying an estimated $233K and bringing the position to 26,795 shares worth $412K. The position accounts for 0.02% of the portfolio, ranked #712.

Entropy Technologies first reported a position in JANX in Q4 2025 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Entropy Technologies held 26,795 shares of Janux Therapeutics worth $412K as of Q2 2026.
  • Entropy Technologies bought 16,094 Janux Therapeutics shares in Q2 2026, an estimated $233K.
  • Janux Therapeutics made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #712 holding.
  • Entropy Technologies first reported a position in Janux Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.